High Dose Pantoprazole can offer New Hope for Tough to Treat GERD

Gastroesophageal reflux disease (GERD) affects over 15% of Indians, often requiring more than standard therapy. While proton pump inhibitors (PPIs) like pantoprazole are widely prescribed, the usual 40 mg dose may fall short in patients with severe symptoms, NSAID use. Clinical evidence and guidelines support doubling the PPI dose in such cases. A once-daily 80 mg dual-release pantoprazole formulation offers a promising solution, enhancing acid suppression, improving patient compliance, and optimizing outcomes in challenging GERD presentations.

References: https://www.ejohg.com/doi/pdf/10.5005/jp-journals-10018-1426